Ignite Creation Date:
2024-05-05 @ 5:35 PM
Last Modification Date:
2024-10-26 @ 9:33 AM
Study NCT ID:
NCT00487656
Status:
COMPLETED
Last Update Posted:
2011-05-18
First Post:
2007-06-15
Brief Title:
Safety and Efficacy of ART-123 in Subjects With Sepsis and Disseminated Intravascular Coagulation
Sponsor:
Artisan Pharma Inc
Organization:
Artisan Pharma Inc
Study Overview
Official Title:
A Randomized Double-Blind Placebo-Controlled Phase-2B Study to Assess the Safety and Efficacy Effects of ART-123 on Subjects With Sepsis and Disseminated Intravascular Coagulation
Status:
COMPLETED
Status Verified Date:
2011-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to see if ART-123 recombinant human soluble thrombomodulin decreases the number of people who die as a result of Disseminated Intravascular Coagulation DIC complication of sepsis
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None